Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT02239328
Official study title

A Study of Patient-reported Outcomes in Patients With Lung or Esophageal Cancer

Study summary

This survey study is looking to determine if patient reported outcomes(using the PROMIS survey) will vary according to the presence of recurrent or metastatic lung or esophageal cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forMetastatic or stage IV · Recurrent or relapsed

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 26, 2018 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Virginia

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Virginia
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting
Metastatic or stage IV→Recurrent or relapsed→
Study topics
Survivorship and quality of life→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • ≥18 years of age
  • Suspected or Known diagnosis of lung or esophageal cancer
  • Willing and able to complete questionnaires
Reasons someone may not be able to joinExclusion criteria
  • Subjects unwilling to provide informed consent
  • Subjects unwilling or unable to answer the questionnaires

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of VirginiaCharlottesville, Virginia

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 26, 2018. Always confirm current availability with the study team.

View original record ↗